• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Research: July Digital Health IPOs, M&A Activity, Public Company Performance Summary

Share:

August 14, 2019

Breaking the digital health IPO drought, there were four initial public offerings (IPOs) during a five-week period from late June to late July, including Livongo, Health Catalyst, Phreesia, and Change Healthcare. The last health IT companies to reach IPO were iRhythym Technologies and Tabula Rasa Healthcare in late 2016 – representing an almost three-year IPO drought.

On July 25, Livongo (chronic care management) shares jumped 36% on the first day of trading to close at $38.10 after issuing at $28/share. The closing price valued the company at approximately $3.5 billion or 27.3x run-rate Q1 2019 revenue. Year-over-year Q1 revenue increased 157% to $32.1mm.

Also on July 25, Health Catalyst (healthcare analytics) shares soared 50% on the first day of trading to close at $39.17 after issuing at $26/share. The closing price valued the company at approximately $1.4 billion or 10x run-rate Q1 2019 revenue. Year-over-year Q1 revenue increased by 71% to $35.2mm.

On July 18, Phreesia (patient payments and registration) shares closed up 39% on the first day of trading to close at $25.08 after issuing at $18/share. The closing price valued the company at approximately $890 million or 7.9x run-rate Q1 2019 (April quarter) 2019 revenue. Year-over-year Q1 revenue increased 18.6% to $28.3mm.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Change Healthcare (healthcare connectivity and revenue cycle) closed up 15% on its June 27 IPO.

Date: August 14, 2019

Source: RamaOnHealthcare

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • FDA Streamlines Pathway to At-home Asymptomatic COVID-19 Test ApprovalFDA Streamlines Pathway to At-home Asymptomatic COVID-19 Test Approval
  • Australia’s Estia Health Surges After $517.7 mln bid from Bain CapitalAustralia’s Estia Health Surges After $517.7 mln bid from Bain Capital
  • Rimidi Announces Integration with MEDITECH GreenfieldRimidi Announces Integration with MEDITECH Greenfield
  • Kemin Industries Acquires U.S. Patent Application for Effective Solution to Control African Swine Fever Virus in FeedKemin Industries Acquires U.S. Patent Application for Effective Solution to Control African Swine Fever Virus in Feed
  • Across Healthcare, Ai Use Cases Expanding and EvolvingAcross Healthcare, Ai Use Cases Expanding and Evolving
  • 7 challenges medical devices pose to providers7 challenges medical devices pose to providers
  • One Drop Acquires Sano’s Continuous Glucose Sensing PlatformOne Drop Acquires Sano’s Continuous Glucose Sensing Platform
  • FDA Extends RCA With COTA to Explore COVID’s Effect on CancerFDA Extends RCA With COTA to Explore COVID’s Effect on Cancer

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications